Eurofins Product Safety Laboratories, 2394 US Highway 130, Suite E, Dayton, NJ 08810, USA.
Int J Toxicol. 2009 Jul-Aug;28(4):318-31. doi: 10.1177/1091581809338955.
PolyGlycopleX (PGX), a novel dietary fiber, produces no mutagenic effects in bacterial tester strains Salmonella typhimurium TA 98, TA 100, TA 1535, and TA 1537 and Escherichia coli WP2 uvrA at concentrations of 0.316, 1.00, 3.16, 10.0, 31.6, and 100 microg/plate. No biologically relevant increases in revertant colonies of any of the 5 strains are observed at any concentration; however, a reduction at 100 microg/plate in TA 1537 is noted. PGX, analyzed for polychromatic erythrocyte micronuclei induction in mice following a single 1x, 0.5x, and 0.2x maximum tolerable dose intraperitoneal treatment, produces no biologically relevant increase in any dose group. Males at 1x maximum tolerable dose show a reduction of micronuclei-containing cells. High-dose animals show signs of systemic toxicity, including a reduction of spontaneous activity, rough fur, palpebral closure, prone position, and constricted abdomen. These genotoxicity studies show PGX to be nonmutagenic in both the Ames bacterial reverse mutation assay and the mammalian erythrocyte micronucleus test.
聚葡萄糖(PGX)是一种新型膳食纤维,在浓度为 0.316、1.00、3.16、10.0、31.6 和 100μg/平板时,对鼠伤寒沙门氏菌 TA98、TA100、TA1535 和 TA1537 以及大肠杆菌 WP2 uvrA 这 5 种细菌测试菌株均无致突变作用。在任何浓度下,任何 5 种测试菌株的回复突变菌落均无明显增加;但在 TA1537 中,在 100μg/平板时观察到减少。PGX 在单次腹腔内 1x、0.5x 和 0.2x 最大耐受剂量处理后,用于分析对小鼠多色红细胞微核的诱导作用,在任何剂量组均未产生明显的生物学相关增加。在 1x 最大耐受剂量下的雄性动物显示出含微核细胞的减少。高剂量动物表现出全身毒性的迹象,包括自发活动减少、皮毛粗糙、眼睑闭合、仰卧位和腹部收缩。这些遗传毒性研究表明,PGX 在细菌回复突变试验和哺乳动物红细胞微核试验中均无致突变性。